These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

777 related articles for article (PubMed ID: 9434723)

  • 1. Contributions of antibody and T cell subsets to protection elicited by immunization with a replication-defective mutant of herpes simplex virus type 1.
    Morrison LA; Knipe DM
    Virology; 1997 Dec; 239(2):315-26. PubMed ID: 9434723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of immunization with a replication-defective mutant of herpes simplex virus 1.
    Morrison LA; Knipe DM
    Virology; 1996 Jun; 220(2):402-13. PubMed ID: 8661391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes.
    Manickan E; Rouse RJ; Yu Z; Wire WS; Rouse BT
    J Immunol; 1995 Jul; 155(1):259-65. PubMed ID: 7602102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal immunization with a herpes simplex virus type 2 replication-defective virus reduces visceral dissemination but not lethal encephalitis in newborn mice after oral challenge.
    Evans IA; Jones CA
    J Infect Dis; 2002 Jun; 185(11):1550-60. PubMed ID: 12023760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective immunity against ocular herpes infection and disease induced by highly immunogenic self-adjuvanting glycoprotein D lipopeptide vaccines.
    Bettahi I; Nesburn AB; Yoon S; Zhang X; Mohebbi A; Sue V; Vanderberg A; Wechsler SL; BenMohamed L
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4643-53. PubMed ID: 17898288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of acute cutaneous herpes simplex virus infection: T cell-mediated viral clearance is dependent upon interferon-gamma (IFN-gamma).
    Smith PM; Wolcott RM; Chervenak R; Jennings SR
    Virology; 1994 Jul; 202(1):76-88. PubMed ID: 7912023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against lethal influenza virus encephalitis by intranasally primed CD8+ memory T cells.
    Stevenson PG; Hawke S; Bangham CR
    J Immunol; 1996 Oct; 157(7):3065-73. PubMed ID: 8816416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Either a CD4(+)or CD8(+)T cell function is sufficient for clearance of infectious virus from trigeminal ganglia and establishment of herpes simplex virus type 1 latency in mice.
    Ghiasi H; Perng G; Nesburn AB; Wechsler SL
    Microb Pathog; 1999 Dec; 27(6):387-94. PubMed ID: 10588911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with replication-defective mutants of herpes simplex virus type 1: sites of immune intervention in pathogenesis of challenge virus infection.
    Morrison LA; Knipe DM
    J Virol; 1994 Feb; 68(2):689-96. PubMed ID: 8289372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of a DNA vaccine encoding herpes simplex virus type 1 (HSV-1) glycoprotein D in decreasing ocular disease severity following corneal HSV-1 challenge.
    Frye TD; Chiou HC; Hull BE; Bigley NJ
    Arch Virol; 2002 Sep; 147(9):1747-59. PubMed ID: 12209314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [T-cell-induced prevention of HSV-1 keratitis by immunization with the synthetic peptide of glycoprotein D].
    Heiligenhaus A; Berra A; Dutt JE; Zhao TZ; Wells PA; Foster CS
    Ophthalmologe; 1994 Oct; 91(5):608-16. PubMed ID: 7812092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4+ T cells are essential in overcoming experimental murine measles encephalitis.
    Finke D; Liebert UG
    Immunology; 1994 Oct; 83(2):184-9. PubMed ID: 7835934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of virus and immune factors to herpes simplex virus type I-induced corneal pathology.
    Hendricks RL; Tumpey TM
    Invest Ophthalmol Vis Sci; 1990 Oct; 31(10):1929-39. PubMed ID: 2170289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonneutralizing antibody against the glycoprotein K of herpes simplex virus type-1 exacerbates herpes simplex virus type-1-induced corneal scarring in various virus-mouse strain combinations.
    Ghiasi H; Cai S; Slanina S; Nesburn AB; Wechsler SL
    Invest Ophthalmol Vis Sci; 1997 May; 38(6):1213-21. PubMed ID: 9152241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of interleukin (IL)-2 and IL-4 in herpes simplex virus type 1 ocular replication and eye disease.
    Ghiasi H; Cai S; Slanina SM; Perng GC; Nesburn AB; Wechsler SL
    J Infect Dis; 1999 May; 179(5):1086-93. PubMed ID: 10191208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of heterosubtypic immunity to lethal influenza A virus infection in fully immunocompetent, T cell-depleted, beta2-microglobulin-deficient, and J chain-deficient mice.
    Epstein SL; Lo CY; Misplon JA; Lawson CM; Hendrickson BA; Max EE; Subbarao K
    J Immunol; 1997 Feb; 158(3):1222-30. PubMed ID: 9013963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpetic stromal keratitis: an immunopathologic disease mediated by CD4+ T lymphocytes.
    Doymaz MZ; Rouse BT
    Invest Ophthalmol Vis Sci; 1992 Jun; 33(7):2165-73. PubMed ID: 1351475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of mucosal and parenteral immunization with a replication-defective mutant of HSV-2 on immune responses and protection from genital challenge.
    Morrison LA; Da Costa XJ; Knipe DM
    Virology; 1998 Mar; 243(1):178-87. PubMed ID: 9527927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of CD8+ T-cells in exacerbation of corneal scarring in mice.
    Osorio Y; Cai S; Hofman FM; Brown DJ; Ghiasi H
    Curr Eye Res; 2004; 29(2-3):145-51. PubMed ID: 15512961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide-induced immune protection of CD8+ T cell-deficient mice against Friend retrovirus-induced disease.
    Kawabata H; Niwa A; Tsuji-Kawahara S; Uenishi H; Iwanami N; Matsukuma H; Abe H; Tabata N; Matsumura H; Miyazawa M
    Int Immunol; 2006 Jan; 18(1):183-98. PubMed ID: 16352628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.